Figure 7.
Individual percent change from baseline in plasma IgG concentration in cynomolgus monkeys following IV (A) or SC (B) rozanolixizumab dosing at 150 mg/kg every 3 days for 13 weeks. Lines represent individual animal data.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.